These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8652830)

  • 1. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes.
    Ottonello L; Morone P; Dapino P; Dallegri F
    Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins.
    Ottonello L; Epstein AL; Dapino P; Barbera P; Morone P; Dallegri F
    Blood; 1999 May; 93(10):3505-11. PubMed ID: 10233903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors.
    Ottonello L; Epstein AL; Mancini M; Tortolina G; Dapino P; Dallegri F
    Br J Cancer; 2001 Aug; 85(3):463-9. PubMed ID: 11487281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes.
    Cemerlíc D; Dadey B; Han T; Vaickus L
    Blood; 1991 Jun; 77(12):2707-15. PubMed ID: 1904285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
    Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
    Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
    Metelitsa LS; Gillies SD; Super M; Shimada H; Reynolds CP; Seeger RC
    Blood; 2002 Jun; 99(11):4166-73. PubMed ID: 12010822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Lym-1 antibody-targeted lysis of B lymphoma cells by neutrophils. Evidence for two mechanisms of FcgammaRII-dependent cytolysis.
    Ottonello L; Epstein AL; Mancini M; Amelotti M; Dapino P; Dallegri F
    J Leukoc Biol; 2000 Nov; 68(5):662-8. PubMed ID: 11073105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.
    Vaickus L; Biddle W; Cemerlić D; Foon KA
    Blood; 1990 Jun; 75(12):2408-16. PubMed ID: 2140949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
    Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29.
    Bungard S; Flieger D; Schweitzer S; Sauerbruch T; Spengler U
    Cancer Immunol Immunother; 1998 Jun; 46(4):213-20. PubMed ID: 9671144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.
    Ragnhammar P; Frödin JE; Trotta PP; Mellstedt H
    Cancer Immunol Immunother; 1994 Oct; 39(4):254-62. PubMed ID: 7525059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
    Liu C; DeNardo G; Tobin E; DeNardo S
    Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
    Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor.
    O'Boyle KP; Colletti D; Mazurek C; Wang Y; Ray SK; Diamond B; Rosenblum MG; Epstein AL; Shochat D; Dutcher JP
    J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):221-30. PubMed ID: 8680650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils.
    Ottonello L; Morone P; Mancini M; Amelotti M; Dapino P; Dallegri F
    Br J Cancer; 1999 May; 80(3-4):331-7. PubMed ID: 10408834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.
    Hornick JL; Khawli LA; Hu P; Lynch M; Anderson PM; Epstein AL
    Blood; 1997 Jun; 89(12):4437-47. PubMed ID: 9192768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
    Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
    Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
    Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
    Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
    Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.